Funding for this research was provided by:
Horizon Pharma (Not applicable)
Text and Data Mining valid from 2018-12-01
Received: 22 August 2018
Accepted: 29 November 2018
First Online: 29 December 2018
Ethics approval and consent to participate
: The initial studies providing the datasets used for these analyses received institutional review board approval at each site, and written informed consent and Health Insurance Portability and Accountability Act assurances were completed for each participant prior to study enrollment.
: Not applicable.
: BFM reports being a clinical investigator for and receiving consulting fees from Horizon Pharma. PEL reports receiving consulting fees from Celgene, Horizon Pharma, Janssen, Medimmune, and Sanofi. AEY reports receiving fees as a contractor from Horizon Pharma.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.